CANDRIAM S.C.A. – Edwards Lifesciences Corporation Transaction History
CANDRIAM S.C.A. portfolio value:
$40.51M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
-13.10%
quarter
Edwards Lifesciences Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +158.24% | 300.42K shares | 22.46M | $82.63 | 490.27K |
| Q2 2022 | share | Increase | +7.98% | 14.03K shares | -2.64M | $95.09 | 189.85K |
| Q1 2022 | share | Increase | +14.51% | 22.27K shares | 805K | $117.72 | 175.81K |
| Q4 2021 | share | Increase | +33.57% | 38.59K shares | 6.87M | $130.68 | 153.54K |
| Q3 2021 | share | Increase | +1.83% | 2.07K shares | 1.32M | $113.21 | 114.94K |
| Q2 2021 | share | Increase | +17.35% | 16.68K shares | 3.26M | $103.57 | 112.87K |
| Q1 2021 | share | 0.00% | 0 shares | -347K | $83.64 | 96.19K | |
| Q4 2020 | share | Increase | +10.23% | 8.92K shares | 1.81M | $91.23 | 96.19K |
| Q3 2020 | share | Decrease | -7.01% | -6.57K shares | 480K | $79.82 | 87.26K |
| Q2 2020 | share | Decrease | -4.09% | -4.00K shares | -953K | $69.11 | 93.83K |
| Q1 2020 | share | 0.00% | 0 shares | -171K | $62.87 | 97.84K | |
| Q4 2019 | share | Increase | +6.34% | 5.83K shares | 865K | $77.76 | 97.84K |
| Q3 2019 | share | Increase | +25.54% | 18.72K shares | 2.25M | $73.3 | 92.00K |
| Q2 2019 | share | Increase | +3.50% | 2.47K shares | -23K | $61.58 | 73.28K |
| Q1 2019 | share | 0.00% | 0 shares | 901K | $63.78 | 70.80K | |
| Q4 2018 | share | Decrease | -4.08% | -3.00K shares | -669K | $51.06 | 70.80K |
| Q3 2018 | share | Decrease | -1.05% | -783 shares | 664K | $58.03 | 73.81K |
| Q2 2018 | share | Decrease | -31.12% | -33.71K shares | -1.41M | $48.52 | 74.60K |
| Q1 2018 | share | Increase | +15.78% | 14.76K shares | 1.52M | $46.51 | 108.31K |
| Q4 2017 | share | Decrease | -1.03% | -972 shares | 71K | $37.57 | 93.54K |
| Q3 2017 | share | Increase | +0.35% | 327 shares | -269K | $36.44 | 94.52K |
| Q2 2017 | share | Decrease | -12.96% | -14.02K shares | 319K | $39.41 | 94.19K |
| Q1 2017 | share | Increase | +60.36% | 40.73K shares | 1.28M | $31.36 | 108.22K |
| Q4 2016 | share | Increase | +14.93% | 8.76K shares | -252K | $31.23 | 67.48K |
| Q3 2016 | share | Decrease | -14.35% | -9.83K shares | 81K | $40.19 | 58.71K |
| Q2 2016 | share | Increase | +5.98% | 3.87K shares | 387K | $33.24 | 68.55K |
| Q1 2016 | share | Increase | 0.00% | 64.68K shares | 1.89M | $29.4 | 64.68K |